Purpose
The prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) is often uncertain. We aimed to utilize analytic morphomics, a high-throughput imaging analysis, to assess if body composition is predictive of post-TACE survival.
Materials and Methods
We included patients from a single center (Ann Arbor VA)who had TACE as the primary treatment forHCC and had a pre-treatment computed tomography scans. Univariate analysis and multivariate conditional inference tree analysis were utilized to identify the morphomic characteristics predictive of 1-year survival. Resultswere validated in an external cohort(University of MichiganHealth System) ofHCC patientswho underwent TACE as their primary treatment.
Results
In the 75 patients in the derivation cohort, median survival was 439 (interquartile range, 377 to 685) days from receipt of TACE, with 1-year survival of 61%. Visceral fat density (VFD) was the only morphomic factor predictive of overall and 1-year survival (p < 0.001). Patients with VFD above the 56th percentile had a 1-year survival of 39% versus 78% for those below the 56th percentile. VFD also correlated with 1-year survival in the external validation cohort (44% vs. 72%, p < 0.001). In a secondary analysis, patients with higher VFD were significantly more likely to experience hepatic decompensation after TACE (p < 0.001).
Conclusion
VFD served as an objective predictor of mortality in patients undergoing TACE, possibly through its ability to predict hepatic decompensation. VFD may serve as a radiographic biomarker in predicting TACE outcomes.
Citations
Citations to this article as recorded by
Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis Anrong Wang, Junfeng Li, Changfeng Li, Hui Zhang, Yingfang Fan, Kuansheng Ma, Qiang Wang Heliyon.2024; 10(3): e25237. CrossRef
Incorporation of quantitative imaging data using artificial intelligence improves risk prediction in veterans with liver disease Grace L. Su, Peng Zhang, Patrick X. Belancourt, Bradley Youles, Binu Enchakalody, Ponni Perumalswami, Akbar Waljee, Sameer Saini Hepatology.2024; 80(4): 928. CrossRef
Morphomics, Survival, and Metabolites in Patients With Metastatic Pancreatic Cancer Valerie Gunchick, Edward Brown, Juan Liu, Jason W. Locasale, Philip A. Philip, Stewart C. Wang, Grace L. Su, Vaibhav Sahai JAMA Network Open.2024; 7(10): e2440047. CrossRef
Role of tumor-specific and whole-body imaging biomarkers for prediction of recurrence in patients with stage III colorectal cancer Amir A. Borhani, Peng Zhang, Brenda Diergaarde, Sophie Darwiche, Kalina Chuperlovska, Stewart C. Wang, Robert E. Schoen, Grace L. Su Abdominal Radiology.2024;[Epub] CrossRef
Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review Elina En Li Cho, Michelle Law, Zhenning Yu, Jie Ning Yong, Claire Shiying Tan, En Ying Tan, Hirokazu Takahashi, Pojsakorn Danpanichkul, Benjamin Nah, Gwyneth Shook Ting Soon, Cheng Han Ng, Darren Jun Hao Tan, Yuya Seko, Toru Nakamura, Asahiro Morishita, S Digestive Diseases and Sciences.2024;[Epub] CrossRef
Impact of sarcopenia on clinical outcomes for patients with resected hepatocellular carcinoma: a retrospective comparison of Eastern and Western cohorts Berend R. Beumer, Kosei Takagi, Stefan Buettner, Yuzo Umeda, Takahito Yagi, Toshiyoshi Fujiwara, Jeroen L.A. van Vugt, Jan N.M. IJzermans International Journal of Surgery.2023; 109(8): 2258. CrossRef
Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study Dan-Dan Wang, Jin-Feng Zhang, Lin-Han Zhang, Meng Niu, Hui-Jie Jiang, Fu-Cang Jia, Shi-Ting Feng Hepatobiliary & Pancreatic Diseases International.2023; 22(6): 594. CrossRef
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial Alexey Surov, Maximilian Thormann, Mattes Hinnerichs, Max Seidensticker, Ricarda Seidensticker, Osman Öcal, Kerstin Schütte, Christoph J. Zech, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Chris Verslype, Bernhard Gebauer, Christian Sengel, Iren Hepatology Communications.2023;[Epub] CrossRef
Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis Shuo Shi, Haiyan Yi, Yi Zheng, Yuxuan Zhao, Dexin Yu European Journal of Radiology.2023; 167: 111025. CrossRef
Preoperative Pectoralis Muscle Index Predicts Distant Metastasis-Free Survival in Breast Cancer Patients Wen-juan Huang, Meng-lin Zhang, Wen Wang, Qing-chun Jia, Jia-rui Yuan, Xin Zhang, Shuang Fu, Yu-xi Liu, Shi-di Miao, Rui-tao Wang Frontiers in Oncology.2022;[Epub] CrossRef
Metabolic abnormalities, liver and body fat in American versus Chinese patients with non‐alcoholic fatty liver disease Wei Zhang, Grace L Su, Kaza Sravanthi, Rui Huang, Yi Wang, Huiying Rao, Lai Wei, Anna S Lok JGH Open.2022; 6(8): 519. CrossRef
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria Berend R. Beumer, Jeroen L.A. van Vugt, Gonzalo Sapisochin, Peter Yoon, Marco Bongini, Di Lu, Xiao Xu, Paolo De Simone, Lorenzo Pintore, Nicolas Golse, Malgorzata Nowosad, William Bennet, Emmanouil Tsochatzis, Evangelia Koutli, Fariba Abbassi, Marco P.A.W Journal of Cachexia, Sarcopenia and Muscle.2022; 13(5): 2373. CrossRef
Bone Densities Assessed by Hounsfield Units at L5 in Computed Tomography Image Independently Predict Hepatocellular Carcinoma Development in Cirrhotic Patients Christopher Yeh, Ming-Wei Lai, Chau-Ting Yeh, Yang-Hsiang Lin, Jeng-Hwei Tseng Journal of Clinical Medicine.2022; 11(19): 5562. CrossRef
What Is the Role of Body Composition Assessment in HCC Management? Pompilia Radu, Maryam Ebadi, Aldo J. Montano-Loza, Jean Francois Dufour Cancers.2022; 14(21): 5290. CrossRef
High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma Leona von Hessen, Marie Roumet, Martin Helmut Maurer, Naomi Lange, Helen Reeves, Jean‐François Dufour, Pompilia Radu Liver International.2021; 41(4): 828. CrossRef
Automated Measurements of Body Composition in Abdominal CT Scans Using Artificial Intelligence Can Predict Mortality in Patients With Cirrhosis Winnie Y. Zou, Binu E. Enchakalody, Peng Zhang, Nidhi Shah, Sameer D. Saini, Nicholas C. Wang, Stewart C. Wang, Grace L. Su Hepatology Communications.2021; 5(11): 1901. CrossRef
The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE Jihye Lim, Kyung Won Kim, Yousun Ko, Il-Young Jang, Yung Sang Lee, Young-Hwa Chung, Han Chu Lee, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Jonggi Choi, Danbi Lee BMC Cancer.2021;[Epub] CrossRef
Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients Kung-Hao Liang, Peng Zhang, Chih-Lang Lin, Stewart C. Wang, Tsung-Hui Hu, Chau-Ting Yeh, Grace L. Su Digestive Diseases and Sciences.2020; 65(7): 2130. CrossRef
Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy Maryam Ebadi, Carlos Moctezuma-Velazquez, Judith Meza-Junco, Vickie E. Baracos, Abha R. DunichandHoedl, Sunita Ghosh, Philippe Sarlieve, Richard J. Owen, Norman Kneteman, Aldo J. Montano-Loza Cancers.2020; 12(2): 356. CrossRef
Review article: prognostic significance of body composition abnormalities in patients with cirrhosis Maryam Ebadi, Rahima A. Bhanji, Puneeta Tandon, Vera Mazurak, Vickie E. Baracos, Aldo J. Montano‐Loza Alimentary Pharmacology & Therapeutics.2020; 52(4): 600. CrossRef
Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis Maryam Ebadi, Rahima A. Bhanji, Abha R. Dunichand-Hoedl, Vera C. Mazurak, Vickie E. Baracos, Aldo J. Montano-Loza Nutrients.2020; 12(11): 3463. CrossRef
Fat Accumulation, Liver Fibrosis, and Metabolic Abnormalities in Chinese Patients With Moderate/Severe Versus Mild Hepatic Steatosis Wei Zhang, Rui Huang, Yi Wang, Huiying Rao, Lai Wei, Grace L. Su, Anna S. Lok Hepatology Communications.2019; 3(12): 1585. CrossRef
Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics Jonghoon Kim, Seung Joon Choi, Seung-Hak Lee, Ho Yun Lee, Hyunjin Park American Journal of Roentgenology.2018; 211(5): 1026. CrossRef
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer Joanne Marie O’Rourke, Vandana Mridhu Sagar, Tahir Shah, Shishir Shetty World Journal of Gastroenterology.2018; 24(39): 4436. CrossRef
The Adverse Impact of Sarcopenia and Visceral Fat Deposition on the Course of Hepatocellular Carcinoma and the Role of Nutritional Interventions Adam McCulloch, Hardip Malhi, Amritpal Dhaliwal, Sheldon Cooper, Tahir Shah European Medical Journal.2018; : 126. CrossRef